Structural requirements for the stability and microsomal transport activity of the human glucose 6-phosphate transporter

被引:27
作者
Chen, LY [1 ]
Lin, BC [1 ]
Pan, CJ [1 ]
Hiraiwa, H [1 ]
Chou, JY [1 ]
机构
[1] NICHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M006439200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deficiencies in glucose 6-phosphate (G6P) transporter (G6PT), a 10-helical endoplasmic reticulum transmembrane protein of 429 amino acids, cause glycogen storage disease type Ib. To date, only three missense mutations in G6PT have been shown to abolish microsomal G6P transport activity. Here, we report the results of structure-function studies on human G6PT and demonstrate that 15 missense mutations and a codon deletion (Delta F93) mutation abolish microsomal G6P uptake activity and that two splicing mutations cause exon skipping. While most missense mutants support the synthesis of G6PT protein similar to that of the wild-type transporter, immunoblot analysis shows that G20D, Delta F93, and I278N mutations, located in helix 1, 2, and 6, respectively, destabilize the G6PT. Further, we demonstrate that G6PT mutants lacking an intact helix 10 are misfolded and undergo degradation within cells. Moreover, amino acids 415-417 in the cytoplasmic tail of the carboxyl-domain, extending from helix 10, also play a critical role in the correct folding of the transporter. However, the last 12 amino acids of the cytoplasmic tail play no essential role(s) in functional integrity of the G6PT. Our results, for the first time, elucidate the structural requirements for the stability and transport activity of the G6PT protein.
引用
收藏
页码:34280 / 34286
页数:7
相关论文
共 32 条
[1]   The gene for glycogen-storage disease type 1b maps to chromosome 11q23 [J].
Annabi, B ;
Hiraiwa, H ;
Mansfield, BC ;
Lei, KJ ;
Ubagai, T ;
Polymeropoulos, MH ;
Moses, SW ;
Parvari, R ;
Hershkovitz, E ;
Mandel, H ;
Fryman, M ;
Chou, JY .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (02) :400-405
[2]  
ARION WJ, 1980, J BIOL CHEM, V255, P396
[3]  
Ausubel F.M., 1992, CURRENT PROTOCOLS MO
[4]   NEUTROPENIA AND IMPAIRED NEUTROPHIL MIGRATION IN TYPE-IB GLYCOGEN-STORAGE DISEASE [J].
BEAUDET, AL ;
ANDERSON, DC ;
MICHELS, VV ;
ARION, WJ ;
LANGE, AJ .
JOURNAL OF PEDIATRICS, 1980, 97 (06) :906-910
[5]  
Chen Y.T., 1995, METABOLIC MOL BASES, P935
[6]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[7]  
Chou JY, 1999, TRENDS ENDOCRIN MET, V10, P104
[8]   Cotranslational protein folding [J].
Fedorov, AN ;
Baldwin, TO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) :32715-32718
[9]   Mutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c [J].
Galli, L ;
Orrico, A ;
Marcolongo, P ;
Fulceri, R ;
Burchell, A ;
Melis, D ;
Parini, R ;
Gatti, R ;
Lam, CW ;
Benedetti, A ;
Sorrentino, V .
FEBS LETTERS, 1999, 459 (02) :255-258
[10]   Structure of the gene mutated in glycogen storage disease type Ib [J].
Gerin, I ;
Veiga-da-Cunha, M ;
Noël, C ;
Van Schaftingen, E .
GENE, 1999, 227 (02) :189-195